Griffin Bruce A, Mensink Ronald P, Lovegrove Julie A
Department of Nutritional Sciences, Faculty of Health and Medical Sciences. University of Surrey, Guildford, Surrey, GU2 7WG, UK.
Nutrition and Movement Sciences, School for Nutrition Toxic and Metab, Faculty of Health, Medicine and Life Sciences, Maastricht University, Minderbroedersberg 4-6, 6211 LK, Maastricht, the Netherlands.
Atherosclerosis. 2021 Jul;328:108-113. doi: 10.1016/j.atherosclerosis.2021.03.024. Epub 2021 Mar 28.
Controversy over fat quality and cardiovascular disease risk stems from a series of meta-analyses of prospective cohort and randomised intervention trials, which found little evidence for a significant relationship between the intake of saturated fat and disease endpoints. Possible explanations for these null findings include difficulties inherent in estimating true food intake, the confounding effects of macronutrient replacement and food composition, and marked inter-individual variation in the response of serum LDL-cholesterol. The aim of this narrative review was to present evidence for the existence and origins of variation in serum LDL-cholesterol response to the replacement of dietary saturated fat, and its potential to explain the controversy over the latter. The review provides evidence to suggest that variation in LDL-responsiveness may harbour significant potential to confound the relationship between saturated fat and atherosclerotic cardiovascular disease risk, thus undermining the effectiveness of the dietary guideline to replace saturated fat with unsaturated fat. It concludes that the identification and application of a simple biomarker of this phenomenon, would make it possible to tailor dietary guidelines to LDL responsive individuals, who stand to gain a greater benefit to their cardiovascular health.
关于脂肪质量与心血管疾病风险的争议源于一系列对前瞻性队列研究和随机干预试验的荟萃分析,这些分析几乎没有发现饱和脂肪摄入量与疾病终点之间存在显著关系的证据。这些无显著结果的可能解释包括估计真实食物摄入量存在的固有困难、宏量营养素替代和食物成分的混杂效应,以及血清低密度脂蛋白胆固醇反应的个体间显著差异。这篇叙述性综述的目的是提供证据,证明血清低密度脂蛋白胆固醇对膳食饱和脂肪替代反应的差异的存在及其来源,以及其解释后者争议的潜力。该综述提供的证据表明,低密度脂蛋白反应性的差异可能具有显著潜力,混淆饱和脂肪与动脉粥样硬化心血管疾病风险之间的关系,从而削弱用不饱和脂肪替代饱和脂肪的饮食指南的有效性。它得出结论,识别和应用这一现象的简单生物标志物,将有可能为对低密度脂蛋白有反应的个体量身定制饮食指南,这些个体的心血管健康有望从中获得更大益处。